Kidney Transplant Antibodies Predict Graft Loss, Injury Renal and Urology News Patients who have complement-binding donor-specific antibodies to human leukocyte antigens (HLAs) after kidney transplantation have a nearly five-fold higher risk of graft loss, according to a study published in the New England Journal of Medicine. |
